BKYI BIO-key International Inc.

BIO-key International, Inc., together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BIO-key International Inc.

Recent Analyst Ratings for BIO-key International Inc.

BIO-key International Inc. SEC Filings

BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

SEC Form 10-Q filed by BIO-key International Inc.

SEC Form 424B3 filed by BIO-key International Inc.

SEC Form EFFECT filed by BIO-key International Inc.

SEC Form S-1 filed by BIO-key International Inc.

BIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-K filed by BIO-key International Inc.

SEC Form NT 10-K filed by BIO-key International Inc.

BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

BIO-key International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

BIO-key International Inc. Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Bio-key upgraded by Maxim Group with a new price target

BIO-key International Inc. Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Depasquale Michael W bought $3,900 worth of shares (5,000 units at $0.78), increasing direct ownership by 10% to 53,519 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W bought $3,320 worth of shares (4,000 units at $0.83), increasing direct ownership by 9% to 48,519 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W bought $4,050 worth of shares (5,000 units at $0.81), increasing direct ownership by 13% to 44,519 units (SEC Form 4)

Depasquale Michael W bought $3,600 worth of shares (20,000 units at $0.18), increasing direct ownership by 7% to 306,827 units (SEC Form 4)

Sullivan James David bought $3,300 worth of shares (20,000 units at $0.17), increasing direct ownership by 5% to 388,171 units (SEC Form 4)

Sullivan James David bought $6,505 worth of shares (39,671 units at $0.16), increasing direct ownership by 12% to 368,171 units (SEC Form 4)

Sullivan James David bought $49,892 worth of shares (285,100 units at $0.17), increasing direct ownership by 175% to 358,500 units (SEC Form 4)

Depasquale Michael W bought $28,875 worth of shares (165,000 units at $0.17), increasing direct ownership by 135% to 286,827 units (SEC Form 4)